Toxicological and teratological study of 5-Br-2-phenyl-indan-1,3-dione, an uricosuric drug.
D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D000831:Animals, Newborn; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D004285:Dogs; D005260:Female; D005298:Fertility; D005313:Fetal Death; D006207:Half-Life; D006452:Hemoglobinometry; D007189:Indans / Q000008:administration & dosage / Q000633:toxicity*; D007192:Indenes / Q000633:toxicity*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007928:Lethal Dose 50; D008214:Lymphocytes; D008297:Male; D051379:Mice; D009929:Organ Size; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D013723:Teratogens / Q000008:administration & dosage / Q000633:toxicity*; D014528:Uricosuric Agents / Q000008:administration & dosage / Q000633:toxicity*
D001786:Blood Glucose; D007189:Indans; D007192:Indenes; D013723:Teratogens; D014528:Uricosuric Agents; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase